ArticleBiophysics reports2026
Leveraging pre-trained AI models for robust promoter sequence design in synthetic biology.
Article in Biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cyanobacteria as a Photosynthetic Chassis for Metabolic Pathway Engineering with Heterologous Gene Expression.Current issues in molecular biology · 2026Review
- High-throughput yeast engineering in biofoundries: towards autonomous and scalable synthetic biology.FEMS yeast research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although artificial intelligence (AI) has begun to be applied in synthetic biology, it is limited by its reliance on large amounts of high-quality data, which presents a significant challenge in synthetic biology. Pre-trained models have profoundly influenced natural language processing by enabling systems to understand and generate human language with remarkable accuracy and efficiency by capturing complex linguistic patterns and contextual nuances. This study applies the concept of pre-trained models to promoter sequence analysis through an innovative pre-training and fine-tuning paradigm. Our analysis reveals that pre-trained DNA models, particularly DNABERT, consistently outperform non-pre-trained models in predicting promoter expression levels across various dataset sizes. Building on DNABERT's strengths, we developed the AI model Pymaker, which specializes in predicting yeast promoter expression levels. Additionally, we introduced a novel base mutation model to simulate promoter mutations, enabling the generation of new promoter sequences. By integrating Pymaker with this mutation model, we effectively screened for high-expression, mutation-resistant promoters. Experimental validation in Saccharomyces cerevisiae showed that these selected promoters significantly enhanced LTB protein expression. Notably, Pymaker's predictions demonstrated superior accuracy, achieving a three-fold increase in protein expression compared to traditional promoters. Our findings highlight the potential of Pymaker not only to identify robust promoters but also to significantly reduce reliance on conventional, labor-intensive experimental methods, heralding a new era in synthetic biology and genetic engineering with practical applications in biopharmaceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.